Novel substituted omega-aroyl(propionyl or butyryl)-L-prolines, pharmaceutical compositions containing them and processes for their preparation
申请人:AMERICAN CYANAMID COMPANY
公开号:EP0010347A1
公开(公告)日:1980-04-30
The present invention provides novel substituted ω-aroyl(propionyl or butyryl) -L-prolines, pharmaceuticat compositions containing them useful for reducing blood pressure by inhibiting the conversion of angiotensin I to angiotensin II, and processes for preparing the novel compounds. The novel compounds are those of the formulae:
wherein n is zero or one; R is hydrogen or alkyl having up to 3 carbon atoms; R2 is hydrogen, phenyl or alkyl having up to 3 carbon atoms; R3 is mercapto, formylthio, benzoylthio, alt noylthio having from 2 to 4 carbon atoms or moieties of the formulae:
and wherein R9 is phenyl or substituted phenyl; R4 is hydrogen, phenyl or alkyl having up to 4 carbon atoms; R5 is hydrogen or alkyl having up to 4 carbon atoms; and ARYL is selected from the group consisting of 1-naphthyl, 2-naphthyl, 4-chloro-1-naphthyl, 5, 6,7, 8-tetrahydro -1-naphthyl, 5, 6, 7, 8-tetrahydro -2-naphthyl, 4-methoxy-1 -naphthyl, 5-acenaphthyl, 4-biphenylyl, 5-indanyl, 4-indanyl and moieties of the formula:
wherein R6 is selected from the group consisting of hydrogen, fluoro, chloro, bromo, trifluoromethyl, cyano, amino, phenoxy, halophenoxy, phenylthio, halophenylthio, p-cyclohexylphenoxy, alkyl having up to 4 carbon atoms, alkoxy having up to4 carbon atoms, alkylamino having up to 4 carbon atoms, alkanoylamino having from 2 to 4 carbon atoms and alkoxycarbonyl having from 2 to 4 carbon atoms, R- is selected from the group consisting of chloro, fluoro, bromo, alkyl having up to 4 carbon atoms and alkoxy having up to 4 carbon atoms, and m is zero, one or two; and the pharmacologically acceptable cationic salts thereof when R5 is hydrogen.
本发明提供了新型取代的ω-芳酰基(丙酰基或丁酰基)-
L-脯氨酸、含有它们的通过抑制
血管紧张素Ⅰ向
血管紧张素Ⅱ的转化来降低血压的药物组合物,以及制备这些新型化合物的工艺。新型化合物为以下式中的化合物:
其中 n 为 0 或 1;R 为
氢或最多 3 个
碳原子的烷基;R2 为
氢、
苯基或最多 3 个
碳原子的烷基;R3 为巯基、甲
硫基、
苯甲酰
硫基、具有 2 至 4 个
碳原子的烷基
硫基或式中的分子:
其中 R9 是
苯基或取代
苯基;R4 是
氢、
苯基或最多 4 个
碳原子的烷基;R5 是
氢或最多 4 个
碳原子的烷基;ARYL 选自由 1-
萘基、2-
萘基、4-
氯-1-
萘基、5、6、7、8-四
氢-1-
萘基、5、6、7、8-四
氢-2-
萘基、
4-甲氧基-1-
萘基、5-
苊基、4-
联苯基、5-
茚基、4-
茚基和式如下的分子组成的组:
其中 R6 选自由
氢、
氟、
氯、
溴、三
氟甲基、
氰基、
氨基、
苯氧基、卤代
苯氧基、
苯硫基、卤代
苯硫基、对
环己基苯氧基、最多 4 个
碳原子的烷基、最多 4 个
碳原子的烷
氧基、最多 4 个
碳原子的烷基
氨基组成的组、R-选自由
氯、
氟、
溴、最多 4 个
碳原子的烷基和最多 4 个
碳原子的烷
氧基组成的组,且 m 为 0、1 或 2;及其药理学上可接受的阳离子盐(当 R5 为
氢时)。